Morgan Stanley’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7936 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7726 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7638 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7694 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7867 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7969 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8075 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8196 |
|
|
2021
Q4 | – | Sell |
-2,278
| Closed | -$300K | – | 8177 |
|
|
2021
Q3 | $327K | Sell |
2,278
-1,202
| -35% | -$202K | ﹤0.01% | 5736 |
|
|
2021
Q2 | $712K | Sell |
3,480
-4,940
| -59% | -$1.1M | ﹤0.01% | 5294 |
|
|
2021
Q1 | $2.53M | Buy |
+8,420
| New | +$2.85M | ﹤0.01% | 4082 |
|
|
2020
Q4 | – | Sell |
-2
| Closed | -$303 | – | 7150 |
|
|
2020
Q3 | $0 | Buy |
+2
| New | +$295 | ﹤0.01% | 6866 |
|
|
2020
Q2 | – | Sell |
-8
| Closed | -$1.09K | – | 6771 |
|
|
2020
Q1 | $1K | Buy |
+8
| New | +$1.24K | ﹤0.01% | 6505 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6815 |
|
|
2019
Q3 | – | Sell |
-3
| Closed | -$2.38K | – | 6808 |
|
|
2019
Q2 | $2K | Buy |
+3
| New | +$2.87K | ﹤0.01% | 6484 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6755 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6779 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6842 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6779 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6732 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6689 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6644 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6534 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6518 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6472 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6378 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6319 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6220 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$20.2K | – | 6349 |
|
|
2015
Q3 | $7K | Hold |
1
| – | – | ﹤0.01% | 6335 |
|
|
2015
Q2 | $19K | Hold |
1
| – | – | ﹤0.01% | 6153 |
|
|
2015
Q1 | $19K | Hold |
1
| – | – | ﹤0.01% | 6068 |
|
|
2014
Q4 | $13K | Hold |
1
| – | – | ﹤0.01% | 6161 |
|
|
2014
Q3 | $37K | Hold |
1
| – | – | ﹤0.01% | 5821 |
|
|
2014
Q2 | $36K | Hold |
1
| – | – | ﹤0.01% | 5872 |
|
|
2014
Q1 | $53K | Hold |
1
| – | – | ﹤0.01% | 5685 |
|
|
2013
Q4 | $52K | Hold |
1
| – | – | ﹤0.01% | 5576 |
|
|
2013
Q3 | $59K | Hold |
1
| – | – | ﹤0.01% | 5178 |
|
|
2013
Q2 | $122K | Buy |
+1
| New | +$96.7K | ﹤0.01% | 5028 |
|
Other funds holding YTEN
CC
CCB
VF
WAM
BC
XT
Morgan Stanley's YTEN Position: Q4 2023 in Review
Morgan Stanley held its Yield10 Bioscience, Inc. Common Stock (YTEN) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7936.
Morgan Stanley first reported a position in YTEN in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.53M in Q1 2021. 17 funds tracked by Wall St. Rank hold YTEN as of Q4 2023.
- Morgan Stanley held 0 shares of Yield10 Bioscience, Inc. Common Stock worth $0 as of Q4 2023.
- Morgan Stanley left its Yield10 Bioscience, Inc. Common Stock share count unchanged in Q4 2023.
- Yield10 Bioscience, Inc. Common Stock made up ﹤0.01% of Morgan Stanley's portfolio in Q4 2023, its #7936 holding.
- Morgan Stanley first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and has held it in 16 quarters since.
- Morgan Stanley's Yield10 Bioscience, Inc. Common Stock position peaked at $2.53M in Q1 2021.
- 17 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q4 2023.
Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.